Complications of Continuous Ambulatory Peritoneal Dialysis

PopovichRP, Moncrief JW, Decherd JF, Bomar JB, Pyle WK. The definition of a novel portable/wearable equilibrium peritoneal dialysis technique [abstr].Am Soc Artif Intern Organs1976; 5(suppl): 64.

10.2214/ajr.174.4.1740987

10.1023/B:UROL.0000025644.90484.ec

10.1038/ki.1993.1

ValeL, Cody J, Wallace S, et al. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.Cochrane Database Syst Rev2004;(4): CD003963.

FerianiM, Dell’Aquila R, La Greca G. The treatment of diabetic end-stage renal disease with peritoneal dialysis.Nephrol Dial Transplant1998; 13 (suppl 8): 53–56.

10.2214/ajr.180.6.1801601

10.1056/NEJM198203183061101

10.2214/ajr.159.5.1344976

YavuzK, Erden A, Ateş K, Erden I. MR peritoneography in complications of continuous ambulatory peritoneal dialysis.Abdom Imaging2005; 30(3): 361–368.

10.1007/s11255-004-1562-1

FinkelsteinFO, Sorkin M, Cramton CW, Nolph K. Initiatives in peritoneal dialysis: where do we go from here?Perit Dial Int1991; 11(3): 274–278.

10.1093/ndt/16.5.1024

LeblancM, Ouimet D, Pichette V. Dialysate leaks in peritoneal dialysis.Semin Dial2001; 14(1): 50–54.

TzamaloukasAH, Gibel LJ, Eisenberg B, et al. Early and late peritoneal dialysate leaks in patients on CAPD.Adv Perit Dial1990; 6: 64–71.

10.1159/000414288

10.1159/000414287

10.1148/131.3.699

10.1046/j.1440-1673.2000.00844.x

PrischlFC, Muhr T, Seiringer EM, et al. Magnetic resonance imaging of the peritoneal cavity among peritoneal dialysis patients, using the dialysate as “contrast medium.”J Am Soc Nephrol2002; 13(1): 197–203.

10.1148/radiographics.17.4.9225388

GokalR, Jakubowski C, King J, et al. Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study.Lancet1987; 2(8568): 1105–1109.

10.2214/ajr.133.1.111

10.1148/rg.233025712

10.1148/rg.271065050

10.1016/j.crad.2007.01.022

10.1002/bjs.1800651113

10.1002/jcu.1870230704

10.2214/ajr.165.6.7484572

10.1148/radiology.164.3.3303119

10.1148/radiology.157.1.4034967

10.2214/ajr.182.2.1820441

10.1093/oxfordjournals.ndt.a027263

10.1016/S0272-6386(12)80818-3

10.1016/S0272-6386(89)80073-3

GokalR, Oreopoulos DG. Is long-term technique survival on continuous ambulatory peritoneal dialysis possible?Perit Dial Int1996; 16(6): 553–555.

10.1016/S0272-6386(99)70225-8

VychytilA, Lorenz M, Schneider B, Hörl WH, Haag-Weber M. New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography.J Am Soc Nephrol1998; 9(2): 290–296.

10.1093/ndt/15.2.231

10.1148/radiology.154.3.3969488

BrownMW, Hamilton DN, Junor BJ. Surgical complications in patients on continuous ambulatory peritoneal dialysis.J R Coll Surg Edinb1983; 28 (3): 141–146.

FlaniganM, Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments.Perit Dial Int2005; 25(2): 132–139.

JoffeP, Christensen AL, Jensen C. Intra-abdominal location of peritoneal catheters during CAPD.Adv Perit Dial1991; 7: 214–217.

GokalR, Alexander S, Ash S, et al. Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. (Official report from the International Society for Peritoneal Dialysis).Perit Dial Int1998; 18(1): 11–33.

10.1046/j.1525-139X.2002.00067.x

10.1259/bjr.72.857.10505008

BargmanJM. Complications of peritoneal dialysis related to increased intra-abdominal pressure.Kidney Int Suppl1993; 40: S75–S80.

MujaisS, Nolph K, Gokal R, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.Perit Dial Int2000; 20(suppl 4): S5–S21.

ScanzianiR, Pozzi M, Pisano L, et al. Imaging work-up for peritoneal access care and peritoneal dialysis complications.Int J Artif Organs2006; 29 (1): 142–152.

10.1002/bjs.1800710323

10.1093/ndt/14.6.1590

10.1080/08860220600925396

10.1111/j.1440-1673.2005.01446.x

10.1001/archinte.1980.00330200077024

10.1016/S0272-6386(96)90501-6

10.1016/S0009-9260(05)80474-X

10.1097/00004728-199803000-00025

MactierRA. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.Adv Perit Dial2000; 16: 223–228.

10.1016/S0009-9260(05)80926-2

AllariaPM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?J Nephrol1999; 12(6): 395–397.

EltoumMA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen.Perit Dial Int2006; 26(2): 203–206.

JunorBJ, McMillan MA. Immunosuppression in sclerosing peritonitis.Adv Perit Dial1993; 9: 187– 189.

10.1093/ndt/13.1.154

WanlessIR, Bargman JM, Oreopoulos DG, Vas SI. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity.Mod Pathol1989; 2(2): 69–74.

TorunD, Oguzkurt L, Sezer S, et al. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.Perit Dial Int2005; 25(6): 596–600.

10.1007/BF01600155

NevalainenPI, Kallio T, Lahtela JT, Mustonen J, Pasternack AI. High peritoneal permeability predisposes to hepatic steatosis in diabetic continuous ambulatory peritoneal dialysis patients receiving intraperitoneal insulin.Perit Dial Int2000; 20(6): 637–642.

10.1093/ndt/gfm002

10.2214/ajr.176.2.1760471

10.1016/S0168-8278(98)80228-6

KallioT, Nevalainen PI, Lahtela JT, Mustonen J, Pasternack A. Hepatic subcapsular steatosis in diabetic CAPD patients treated with intraperitoneal insulin: description of a typical pattern.Acta Radiol2001; 42(3): 323–325.

10.1097/00004424-199112000-00002